search
Back to results

RCT Investigating EMDR for Suicidal Ideation

Primary Purpose

Suicidal Ideation

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Eye Movement Desensitization and Reprocessing (EMDR)
Usual care
Sponsored by
University of Alberta
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Suicidal Ideation focused on measuring Eye movement desensitization and Reprocessing, Suicide

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria include

  1. adults (ages 18 to 65) with suicidal ideation in the last week.
  2. Participants must volunteer to be in the study, be able to give informed consent and be able to follow up twice weekly until treatment is complete (a total of 12 sessions).
  3. Participants must have a primary service provider.
  4. Participants must have access to their own laptop or desktop computer that enables BLS with a working screen, camera, and microphone, and access to a quiet, private, well-lit space for therapy.
  5. Participants must be willing to refrain from benzodiazepine, cannabis or illicit substance use in the 24 hours before or after EMDR sessions.
  6. Participants must be willing to adhere to the study safety precautions

Exclusion criteria

  1. At the time of assessment, suicidal ideation is not accompanied by intent or plan to follow through with suicide.
  2. Known pregnancy, as there is limited information about the impact of EMDR in pregnancy.
  3. DES score above 34 or severe dissociative symptoms (see below), psychotic symptoms or manic symptoms.
  4. Participants undergoing or planning to undergo electroconvulsive therapy (ECT) or another trauma focused psychotherapy in the 4-month study period.

Referred potential participants will also be excluded on the basis of the assessment interview if they report a history of severe dissociative symptoms in keeping with a separate dissociative disorder, such as

  1. hearing internal voices,
  2. amnestic episodes, or dissociative fugue states
  3. passivity experiences or first rank symptoms under stress, or
  4. the subjective experience of having alter personality self-states.
  5. severe isolation of affect, with inability to feel body sensations or tune into emotions

Sites / Locations

  • Alberta Hospital Edmonton - recruiting from AHS clinics internallyRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Virtual EMDR

Treatment as usual

Arm Description

Patients will receive 1 to 3 preparation sessions (which will include psychoeducation and preparation exercises before EMDR), followed by up to 12 EMDR sessions, delivered over encrypted Zoom videoconferencing. EMDR is an evidence based trauma therapy. These EMDR sessions will focus on the experiences, urges or negative thoughts associated with their suicidal thoughts. The sessions will be 90 minutes in length and occur twice per week. This group will also have access to usual psychiatric care, which usually includes a family doctor or psychiatrist, mental health therapist and having access to Edmonton's community mental health programs.

This group will also have access to usual care, which usually includes a family doctor or psychiatrist, mental health therapist and having access to Edmonton's community mental health programs.

Outcomes

Primary Outcome Measures

Beck Scale for Suicide ideation (BSS)
21 item questionnaire on suicidal ideation and behaviour in past 1week. Score range 0 to 42, with higher scores worse in outcome.
Beck Scale for Suicide ideation (BSS)
21 item questionnaire on suicidal ideation and behaviour in past 1week. Score range 0 to 42, with higher scores worse in outcome.
Beck Scale for Suicide ideation (BSS)
21 item questionnaire on suicidal ideation and behaviour in past 1week. Score range 0 to 42, with higher scores worse in outcome.
Columbia Suicide Severity Rating Scale (CSSRS) Recent (self report of past 1 week)
6 questions on suicidal ideation. First Questions 3, 4, and 5 are answered only if Question 2 ("Have you actually had any thoughts of killing yourself") is answered as a yes. Questions 3 to 5 elaborate on suicidal ideation. Scored as "yes or no" for each question, as dichotomous variables.
Columbia Suicide Severity Rating Scale (CSSRS) Recent (self report of past 1 week)
6 questions on suicidal ideation. First Questions 3, 4, and 5 are answered only if Question 2 ("Have you actually had any thoughts of killing yourself") is answered as a yes. Questions 3 to 5 elaborate on suicidal ideation. Scored as "yes or no" for each question, as dichotomous variables.
Columbia Suicide Severity Rating Scale (CSSRS) Recent (self report of past 1 week)
6 questions on suicidal ideation. First Questions 3, 4, and 5 are answered only if Question 2 ("Have you actually had any thoughts of killing yourself") is answered as a yes. Questions 3 to 5 elaborate on suicidal ideation. Scored as "yes or no" for each question, as dichotomous variables.

Secondary Outcome Measures

ACES Questionnaire (ACES)
10 questions about childhood adversity, which can be added. Score ranges from 0 to 10, with higher number indicating worse adversity before age 18.
DES II (Dissociative Experiences Scale II).
28 item scale, with score ranging from 0 to 100, with higher score indicating higher dissociative symptoms and severity.
DES II (Dissociative Experiences Scale II).
28 item scale, with score ranging from 0 to 100, with higher score indicating higher dissociative symptoms and severity.
BDI II (Beck Depression Inventory II)
21 item questionnaire on depressive symptoms, score ranges from 0 to 63, with higher scores indicating worse depression.
BDI II (Beck Depression Inventory II)
21 item questionnaire on depressive symptoms, score ranges from 0 to 63, with higher scores indicating worse depression.
BDI II (Beck Depression Inventory II)
21 item questionnaire on depressive symptoms, score ranges from 0 to 63, with higher scores indicating worse depression.
PHQ-9 (Patient Health Questionnaire 9).
Nine item questionnaire on depressive symptoms, ranging from 0 (not at all) to 3 (nearly every day) for each item, scores range from 0 to 27 (worst symptoms). Then symptoms ranked as either Not difficult, somewhat difficult, Very difficult or Extremely difficult.
PHQ-9 (Patient Health Questionnaire 9).
Nine item questionnaire on depressive symptoms, ranging from 0 (not at all) to 3 (nearly every day) for each item, scores range from 0 to 27 (worst symptoms). Then symptoms ranked as either Not difficult, somewhat difficult, Very difficult or Extremely difficult.
PHQ-9 (Patient Health Questionnaire 9).
Nine item questionnaire on depressive symptoms, ranging from 0 (not at all) to 3 (nearly every day) for each item, scores range from 0 to 27 (worst symptoms). Then symptoms ranked as either Not difficult, somewhat difficult, Very difficult or Extremely difficult.
GAD 7 (Generalized Anxiety Disorder 7)
7 Item questionnaire on anxiety symptoms, each ranked from 0 (not at all) to 3 (nearly every day), with a score ranging from 0 to 21. Higher scores indicate worse anxiety.
GAD 7 (Generalized Anxiety Disorder 7)
7 Item questionnaire on anxiety symptoms, each ranked from 0 (not at all) to 3 (nearly every day), with a score ranging from 0 to 21. Higher scores indicate worse anxiety.
GAD 7 (Generalized Anxiety Disorder 7)
7 Item questionnaire on anxiety symptoms, each ranked from 0 (not at all) to 3 (nearly every day), with a score ranging from 0 to 21. Higher scores indicate worse anxiety.
IES-R (Impact of Events Revised)
22 item questionnaire on traumatic or stressful events. Each item ranges from 0 (not at all) to 4 (extremely), with scores ranging from 0 to 88 (higher is more severe).
IES-R (Impact of Events Revised)
22 item questionnaire on traumatic or stressful events. Each item ranges from 0 (not at all) to 4 (extremely), with scores ranging from 0 to 88 (higher is more severe).
IES-R (Impact of Events Revised)
22 item questionnaire on traumatic or stressful events. Each item ranges from 0 (not at all) to 4 (extremely), with scores ranging from 0 to 88 (higher is more severe).
DERS (Difficulties in Emotion Regulation Scale)
36 item questionnaire on emotion regulation, with each question ranked from 1 (almost never; 0-10% of the time) to 5 (almost always; 91-100% of the time). Scores range from 36 to 180, with higher scores indicating worse emotion regulation. Subscales indicate specific type of difficulties.
DERS (Difficulties in Emotion Regulation Scale)
36 item questionnaire on emotion regulation, with each question ranked from 1 (almost never; 0-10% of the time) to 5 (almost always; 91-100% of the time). Scores range from 36 to 180, with higher scores indicating worse emotion regulation. Subscales indicate specific type of difficulties.
DERS (Difficulties in Emotion Regulation Scale)
36 item questionnaire on emotion regulation, with each question ranked from 1 (almost never; 0-10% of the time) to 5 (almost always; 91-100% of the time). Scores range from 36 to 180, with higher scores indicating worse emotion regulation. Subscales indicate specific type of difficulties.
Healthcare care utilization
Differences between the two arms with respect to number of emergency room visits and hospitalizations in the year before and after study.

Full Information

First Posted
November 26, 2019
Last Updated
March 31, 2023
Sponsor
University of Alberta
Collaborators
Alberta Health services
search

1. Study Identification

Unique Protocol Identification Number
NCT04181047
Brief Title
RCT Investigating EMDR for Suicidal Ideation
Official Title
RCT Investigating Virtual Eye Movement Desensitization and Reprocessing (EMDR) for Adults With Suicidal Ideation
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 12, 2021 (Actual)
Primary Completion Date
January 1, 2024 (Anticipated)
Study Completion Date
August 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Alberta
Collaborators
Alberta Health services

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Suicide is a major public health issue, and is the 9th leading cause of death overall. Suicidal thinking and behaviours have been linked to painful childhood experiences, stressors, and psychological trauma. Stressful experiences are also strongly linked to the development of a variety of mental health problems, including anxiety, depression and posttraumatic stress disorder. However, patients with suicidal ideas are often left out of trauma treatment, for fear that it will worsen their distress and increase their suicidal thinking. However, there is preliminary evidence that treating posttraumatic stress symptoms in patients with suicidal thoughts can lead to improvement in their symptoms and a reduction in suicidal thinking. For many individuals, overwhelming emotions and/or painful negative beliefs stemming from traumatic experiences contribute to a desire to escape though suicide or self-harm. Eye Movement Desensitization and Reprocessing (EMDR) is an evidence-based therapy for posttraumatic stress disorder that desensitizes painful memories, so that reminders in the present no longer provoke the overwhelming emotional responses. It has also been used for depression and a variety of other mental health problems. This study aims to test the safety and effectiveness of virtual/remotely delivered EMDR for adults with suicidal ideation. Patients will be randomly assigned to receive either EMDR therapy plus Treatment as usual (TAU) or TAU alone. Symptoms of anxiety, depression, post-traumatic stress, distressing emotions, and suicidal thinking will be compared before and after therapy. For the EMDR group, side effects to EMDR will be tracked. The number of emergency room visits and hospitalizations will also be compared before and after therapy for each group.
Detailed Description
Suicide is the second leading cause of death among those aged 10-29 years, the 9th leading cause of death overall, and there are 4000 completed suicides per year in Canada. Adverse childhood experiences, interpersonal stressors and trauma correlate strongly with suicidal behaviour and the later development of psychopathology such as depression. For many individuals, overwhelming emotions and/or painful negative beliefs stemming from traumatic experiences contribute to a desire to escape though suicide or self-harm. Eye Movement Desensitization and Reprocessing (EMDR) is an evidence-based therapy for posttraumatic stress disorder that desensitizes painful memories, so that reminders in the present no longer provoke the overwhelming emotional responses. The COVID-19 pandemic has forced a rapid shift from in-person psychotherapy to remotely delivered psychotherapy services, both to reduce the spread of COVID-19 as well as to maintain access to services. Given this rapid shift to remote delivery and the need for a review of evidence, a recent systematic scoping review was undertaken regarding the scope and quality of peer reviewed literature on remotely delivered psychotherapeutic digital health interventions for military members, veterans and public safety personnel with posttraumatic stress injury (Jones et al 2020). This review yielded 38 studies for inclusion, demonstrating level 1a evidence for prolonged exposure therapy, cognitive processing therapy, behavioral activation and therapeutic exposure in this population. There was evidence that remote delivery of these therapies can be as effective as in-person treatment, and also possibly reduce stigma and improve access to care. There was limited information about EMDR, despite the fact that online EMDR has been widely adopted around the world clinically. This project had originally aimed to enroll inpatients in face to face therapy and transition them to the outpatient environment. However, the COVID-19 pandemic has resulted in shorter inpatient length of stay, extremely limited mobility for inpatients on and off the units, and shortages of appropriate spaces, making this untenable. There has also been an increase in demand for mental health services at the same time as a reduction in availability of in-person mental health supports. Furthermore, public health measures have necessitated periodic self-isolation, leading to clinic cancellations. For all these reasons, this project will deliver EMDR via Zoom videoconferencing, rather than in person. This real-world, non-blinded randomized study aims to evaluate the safety and efficacy of EMDR for adults (ages 18 to 65) with suicidal ideation. Eighty participants will be randomized into one of two groups. Group one will receive EMDR therapy to desensitize and reprocess the experiences associated with suicidal thinking. This will be delivered online via encrypted Zoom, due to the COVID-19 pandemic. Group two will be randomized to "treatment as usual" (TAU), which will serve as a control group. TAU will include regular psychiatric care. Clinical measures of anxiety, depression, post-traumatic symptoms, emotional dysregulation, and suicidal thinking will be compared before and after therapy. The impact on emergency room visits, re-hospitalizations and healthcare costs will also be evaluated one year after study completion.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Suicidal Ideation
Keywords
Eye movement desensitization and Reprocessing, Suicide

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Non-blinded randomized controlled trial.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Virtual EMDR
Arm Type
Experimental
Arm Description
Patients will receive 1 to 3 preparation sessions (which will include psychoeducation and preparation exercises before EMDR), followed by up to 12 EMDR sessions, delivered over encrypted Zoom videoconferencing. EMDR is an evidence based trauma therapy. These EMDR sessions will focus on the experiences, urges or negative thoughts associated with their suicidal thoughts. The sessions will be 90 minutes in length and occur twice per week. This group will also have access to usual psychiatric care, which usually includes a family doctor or psychiatrist, mental health therapist and having access to Edmonton's community mental health programs.
Arm Title
Treatment as usual
Arm Type
Active Comparator
Arm Description
This group will also have access to usual care, which usually includes a family doctor or psychiatrist, mental health therapist and having access to Edmonton's community mental health programs.
Intervention Type
Behavioral
Intervention Name(s)
Eye Movement Desensitization and Reprocessing (EMDR)
Intervention Description
Psychotherapy.
Intervention Type
Other
Intervention Name(s)
Usual care
Intervention Description
Access to usual care, including psychiatrist, medications, mental health therapist, general community mental health programs. TAU will NOT include electroconvulsive therapy or another trauma specific psychotherapy.
Primary Outcome Measure Information:
Title
Beck Scale for Suicide ideation (BSS)
Description
21 item questionnaire on suicidal ideation and behaviour in past 1week. Score range 0 to 42, with higher scores worse in outcome.
Time Frame
Baseline
Title
Beck Scale for Suicide ideation (BSS)
Description
21 item questionnaire on suicidal ideation and behaviour in past 1week. Score range 0 to 42, with higher scores worse in outcome.
Time Frame
2 months after baseline
Title
Beck Scale for Suicide ideation (BSS)
Description
21 item questionnaire on suicidal ideation and behaviour in past 1week. Score range 0 to 42, with higher scores worse in outcome.
Time Frame
4 months after baseline
Title
Columbia Suicide Severity Rating Scale (CSSRS) Recent (self report of past 1 week)
Description
6 questions on suicidal ideation. First Questions 3, 4, and 5 are answered only if Question 2 ("Have you actually had any thoughts of killing yourself") is answered as a yes. Questions 3 to 5 elaborate on suicidal ideation. Scored as "yes or no" for each question, as dichotomous variables.
Time Frame
Baseline
Title
Columbia Suicide Severity Rating Scale (CSSRS) Recent (self report of past 1 week)
Description
6 questions on suicidal ideation. First Questions 3, 4, and 5 are answered only if Question 2 ("Have you actually had any thoughts of killing yourself") is answered as a yes. Questions 3 to 5 elaborate on suicidal ideation. Scored as "yes or no" for each question, as dichotomous variables.
Time Frame
2 months
Title
Columbia Suicide Severity Rating Scale (CSSRS) Recent (self report of past 1 week)
Description
6 questions on suicidal ideation. First Questions 3, 4, and 5 are answered only if Question 2 ("Have you actually had any thoughts of killing yourself") is answered as a yes. Questions 3 to 5 elaborate on suicidal ideation. Scored as "yes or no" for each question, as dichotomous variables.
Time Frame
4 months
Secondary Outcome Measure Information:
Title
ACES Questionnaire (ACES)
Description
10 questions about childhood adversity, which can be added. Score ranges from 0 to 10, with higher number indicating worse adversity before age 18.
Time Frame
Baseline only
Title
DES II (Dissociative Experiences Scale II).
Description
28 item scale, with score ranging from 0 to 100, with higher score indicating higher dissociative symptoms and severity.
Time Frame
Baseline
Title
DES II (Dissociative Experiences Scale II).
Description
28 item scale, with score ranging from 0 to 100, with higher score indicating higher dissociative symptoms and severity.
Time Frame
4 months after baseline
Title
BDI II (Beck Depression Inventory II)
Description
21 item questionnaire on depressive symptoms, score ranges from 0 to 63, with higher scores indicating worse depression.
Time Frame
Baseline
Title
BDI II (Beck Depression Inventory II)
Description
21 item questionnaire on depressive symptoms, score ranges from 0 to 63, with higher scores indicating worse depression.
Time Frame
2 months after baseline
Title
BDI II (Beck Depression Inventory II)
Description
21 item questionnaire on depressive symptoms, score ranges from 0 to 63, with higher scores indicating worse depression.
Time Frame
4 months after baseline
Title
PHQ-9 (Patient Health Questionnaire 9).
Description
Nine item questionnaire on depressive symptoms, ranging from 0 (not at all) to 3 (nearly every day) for each item, scores range from 0 to 27 (worst symptoms). Then symptoms ranked as either Not difficult, somewhat difficult, Very difficult or Extremely difficult.
Time Frame
Baseline
Title
PHQ-9 (Patient Health Questionnaire 9).
Description
Nine item questionnaire on depressive symptoms, ranging from 0 (not at all) to 3 (nearly every day) for each item, scores range from 0 to 27 (worst symptoms). Then symptoms ranked as either Not difficult, somewhat difficult, Very difficult or Extremely difficult.
Time Frame
2 months after baseline
Title
PHQ-9 (Patient Health Questionnaire 9).
Description
Nine item questionnaire on depressive symptoms, ranging from 0 (not at all) to 3 (nearly every day) for each item, scores range from 0 to 27 (worst symptoms). Then symptoms ranked as either Not difficult, somewhat difficult, Very difficult or Extremely difficult.
Time Frame
4 months after baseline
Title
GAD 7 (Generalized Anxiety Disorder 7)
Description
7 Item questionnaire on anxiety symptoms, each ranked from 0 (not at all) to 3 (nearly every day), with a score ranging from 0 to 21. Higher scores indicate worse anxiety.
Time Frame
Baseline
Title
GAD 7 (Generalized Anxiety Disorder 7)
Description
7 Item questionnaire on anxiety symptoms, each ranked from 0 (not at all) to 3 (nearly every day), with a score ranging from 0 to 21. Higher scores indicate worse anxiety.
Time Frame
2 months after baseline
Title
GAD 7 (Generalized Anxiety Disorder 7)
Description
7 Item questionnaire on anxiety symptoms, each ranked from 0 (not at all) to 3 (nearly every day), with a score ranging from 0 to 21. Higher scores indicate worse anxiety.
Time Frame
4 months after baseline
Title
IES-R (Impact of Events Revised)
Description
22 item questionnaire on traumatic or stressful events. Each item ranges from 0 (not at all) to 4 (extremely), with scores ranging from 0 to 88 (higher is more severe).
Time Frame
Baseline
Title
IES-R (Impact of Events Revised)
Description
22 item questionnaire on traumatic or stressful events. Each item ranges from 0 (not at all) to 4 (extremely), with scores ranging from 0 to 88 (higher is more severe).
Time Frame
2 months after baseline
Title
IES-R (Impact of Events Revised)
Description
22 item questionnaire on traumatic or stressful events. Each item ranges from 0 (not at all) to 4 (extremely), with scores ranging from 0 to 88 (higher is more severe).
Time Frame
4 months after baseline
Title
DERS (Difficulties in Emotion Regulation Scale)
Description
36 item questionnaire on emotion regulation, with each question ranked from 1 (almost never; 0-10% of the time) to 5 (almost always; 91-100% of the time). Scores range from 36 to 180, with higher scores indicating worse emotion regulation. Subscales indicate specific type of difficulties.
Time Frame
Baseline
Title
DERS (Difficulties in Emotion Regulation Scale)
Description
36 item questionnaire on emotion regulation, with each question ranked from 1 (almost never; 0-10% of the time) to 5 (almost always; 91-100% of the time). Scores range from 36 to 180, with higher scores indicating worse emotion regulation. Subscales indicate specific type of difficulties.
Time Frame
2 months after baseline
Title
DERS (Difficulties in Emotion Regulation Scale)
Description
36 item questionnaire on emotion regulation, with each question ranked from 1 (almost never; 0-10% of the time) to 5 (almost always; 91-100% of the time). Scores range from 36 to 180, with higher scores indicating worse emotion regulation. Subscales indicate specific type of difficulties.
Time Frame
4 months after baseline
Title
Healthcare care utilization
Description
Differences between the two arms with respect to number of emergency room visits and hospitalizations in the year before and after study.
Time Frame
Comparing one year before to one year after study enrolment.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria include adults (ages 18 to 65) with suicidal ideation in the last week. Participants must volunteer to be in the study, be able to give informed consent and be able to follow up twice weekly until treatment is complete (a total of 12 sessions). Participants must have a primary service provider. Participants must have access to their own laptop or desktop computer that enables BLS with a working screen, camera, and microphone, and access to a quiet, private, well-lit space for therapy. Participants must be willing to refrain from benzodiazepine, cannabis or illicit substance use in the 24 hours before or after EMDR sessions. Participants must be willing to adhere to the study safety precautions Exclusion criteria At the time of assessment, suicidal ideation is not accompanied by intent or plan to follow through with suicide. Known pregnancy, as there is limited information about the impact of EMDR in pregnancy. DES score above 34 or severe dissociative symptoms (see below), psychotic symptoms or manic symptoms. Participants undergoing or planning to undergo electroconvulsive therapy (ECT) or another trauma focused psychotherapy in the 4-month study period. Referred potential participants will also be excluded on the basis of the assessment interview if they report a history of severe dissociative symptoms in keeping with a separate dissociative disorder, such as hearing internal voices, amnestic episodes, or dissociative fugue states passivity experiences or first rank symptoms under stress, or the subjective experience of having alter personality self-states. severe isolation of affect, with inability to feel body sensations or tune into emotions
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lisa M Burback, MD
Phone
780-342-5410
Email
burback@ualberta.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Olga Winkler, MD
Phone
780-342-5410
Email
olga.winkler@albertahealthservices.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lisa M Burback, MD
Organizational Affiliation
University of Alberta
Official's Role
Principal Investigator
Facility Information:
Facility Name
Alberta Hospital Edmonton - recruiting from AHS clinics internally
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T5J 2J7
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shelley M Daubert
Phone
780.342.7640
Email
shelley.daubert@ahs.ca
First Name & Middle Initial & Last Name & Degree
DeAnn Hunter
Phone
780.342.5200
Email
deann.hunter@ahs.ca
First Name & Middle Initial & Last Name & Degree
Lisa M Burback, MD
First Name & Middle Initial & Last Name & Degree
Adam Abba-Aji, MD

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
This is not in the plan.
Citations:
PubMed Identifier
31695382
Citation
Fereidouni Z, Behnammoghadam M, Jahanfar A, Dehghan A. The Effect of Eye Movement Desensitization and Reprocessing (EMDR) on the severity of suicidal thoughts in patients with major depressive disorder: a randomized controlled trial. Neuropsychiatr Dis Treat. 2019 Aug 27;15:2459-2466. doi: 10.2147/NDT.S210757. eCollection 2019.
Results Reference
background
PubMed Identifier
31072317
Citation
van Bentum JS, Sijbrandij M, Kerkhof AJFM, Huisman A, Arntz AR, Holmes EA, Franx G, Mokkenstorm J, Huibers MJH. Treating repetitive suicidal intrusions using eye movements: study protocol for a multicenter randomized clinical trial. BMC Psychiatry. 2019 May 9;19(1):143. doi: 10.1186/s12888-019-2129-0.
Results Reference
background
PubMed Identifier
28665329
Citation
Bentum JSV, Sijbrandij M, Huibers MJH, Huisman A, Arntz A, Holmes EA, Kerkhof AJFM. Treatment of Intrusive Suicidal Imagery Using Eye Movements. Int J Environ Res Public Health. 2017 Jun 30;14(7):714. doi: 10.3390/ijerph14070714.
Results Reference
background
PubMed Identifier
30013726
Citation
Van Woudenberg C, Voorendonk EM, Bongaerts H, Zoet HA, Verhagen M, Lee CW, van Minnen A, De Jongh A. Effectiveness of an intensive treatment programme combining prolonged exposure and eye movement desensitization and reprocessing for severe post-traumatic stress disorder. Eur J Psychotraumatol. 2018 Jul 10;9(1):1487225. doi: 10.1080/20008198.2018.1487225. eCollection 2018.
Results Reference
background
PubMed Identifier
34734835
Citation
Winkler O, Dhaliwal R, Greenshaw A, O'Shea K, Abba-Aji A, Chima C, Purdon SE, Burback L. Web-Based Eye Movement Desensitization and Reprocessing for Adults With Suicidal Ideation: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2021 Nov 4;10(11):e30711. doi: 10.2196/30711.
Results Reference
derived
Links:
URL
https://www.health.org.uk/improvement-projects/using-eye-movement-desensitisation-and-reprocessing-emdr-with-patients-with
Description
This link has a downloadable report outlining a pilot program using EMDR for people in suicidal crisis in the UK, led by Simon Proudlock.

Learn more about this trial

RCT Investigating EMDR for Suicidal Ideation

We'll reach out to this number within 24 hrs